Prediction Models of Adnexal Masses: State-of-the-Art Review
- PMID: 33908613
- DOI: 10.1097/OGX.0000000000000873
Prediction Models of Adnexal Masses: State-of-the-Art Review
Abstract
Importance: Several predictive models and scoring systems have been developed to differentiate between benign and malignant ovarian masses, in order to guide effective management. These models use combinations of patient characteristics, ultrasound markers, and biochemical markers.
Objective: The aim of this study was to describe, compare, and prioritize, according to their strengths and qualities, all the adnexal prediction models.
Evidence acquisition: This was a state-of-the-art review, synthesizing the findings of the current published literature on the available prediction models of adnexal masses.
Results: The existing models include subjective assessment by expert sonographers, the International Ovarian Tumor Analysis models (logistic regression models 1 and 2, Simple Rules, 3-step strategy, and ADNEX [Assessment of Different NEoplasias in the adneXa] model), the Risk of Malignancy Index, the Risk of Malignancy Ovarian Algorithm, the Gynecologic Imaging Reporting and Data System, and the Ovarian-Adnexal Reporting and Data System. Overall, subjective assessment appears to be superior to all prediction models. However, the International Ovarian Tumor Analysis models are probably the best available methods for nonexpert examiners. The Ovarian-Adnexal Reporting and Data System is an international approach that incorporates both the common European and North American approaches, but still needs to be validated.
Conclusions: Many prediction models exist for the assessment of adnexal masses. The adoption of a particular model is based on local guidelines, as well as sonographer's experience. The safety of expectant management of adnexal masses with benign ultrasound morphology is still under investigation.
Similar articles
-
Prospective external validation of IOTA three-step strategy for characterizing and classifying adnexal masses and retrospective assessment of alternative two-step strategy using simple-rules risk.Ultrasound Obstet Gynecol. 2019 May;53(5):693-700. doi: 10.1002/uog.20163. Ultrasound Obstet Gynecol. 2019. PMID: 30353585
-
Scoring systems for the evaluation of adnexal masses nature: current knowledge and clinical applications.J Obstet Gynaecol. 2021 Apr;41(3):340-347. doi: 10.1080/01443615.2020.1732892. Epub 2020 Apr 29. J Obstet Gynaecol. 2021. PMID: 32347750 Review.
-
Estimating risk of malignancy in adnexal masses: external validation of the ADNEX model and comparison with other frequently used ultrasound methods.Ultrasound Obstet Gynecol. 2017 Jun;49(6):784-792. doi: 10.1002/uog.17225. Ultrasound Obstet Gynecol. 2017. PMID: 27514486 Free PMC article.
-
Evaluating use of two-step International Ovarian Tumor Analysis strategy to classify adnexal masses identified in pregnancy: pilot study.Ultrasound Obstet Gynecol. 2024 Dec;64(6):808-817. doi: 10.1002/uog.27707. Ultrasound Obstet Gynecol. 2024. PMID: 38787921 Free PMC article.
-
Guideline No. 403: Initial Investigation and Management of Adnexal Masses.J Obstet Gynaecol Can. 2020 Aug;42(8):1021-1029.e3. doi: 10.1016/j.jogc.2019.08.044. J Obstet Gynaecol Can. 2020. PMID: 32736853 Review.
Cited by
-
Efficacy of a combination of O-RADS, CEUS, and CA125, in identification of ovary-adnexal malignant lesions.Am J Cancer Res. 2025 Feb 15;15(2):631-642. doi: 10.62347/JHJJ1149. eCollection 2025. Am J Cancer Res. 2025. PMID: 40084369 Free PMC article.
-
Application of O-RADS US combined with MV-Flow to diagnose ovarian-adnexal tumors.Ultrasonography. 2024 Jan;43(1):15-24. doi: 10.14366/usg.23061. Epub 2023 Aug 25. Ultrasonography. 2024. PMID: 38061878 Free PMC article.
-
Imaging Evaluation of Ovarian Masses in a Pediatric Population: A Comprehensive Overview.Cancers (Basel). 2025 Jul 11;17(14):2316. doi: 10.3390/cancers17142316. Cancers (Basel). 2025. PMID: 40723200 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical